Longevity Health Holdings, Inc.
XAGE Consumer Defensive Household & Personal Products
Longevity Health Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 million, up 3,702.8% from fiscal 2024. In the quarter to June 2026, revenue fell 21.4%, EPS grew 51.3% and free cash flow grew 73.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow XAGE
Longevity Health Holdings, Inc. (XAGE) P/E ratio
Longevity Health Holdings, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 34.6× (April 2024) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 6 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GROV Grove Collaborative Holdings, Inc. compare | n/m |
| TANH Tantech Holdings Ltd. compare | n/m |
| BRSHF Bruush Oral Care Inc. compare | n/m |
| XAGE Longevity Health Holdings, Inc. | n/m |
| SLSN Solesence, Inc. compare | n/m |
| UG United-Guardian, Inc. compare | 12.7× |
| DSY Big Tree Cloud Holdings Limited compare | 18.1× |
| ATTT Atlas Trinity Tech Limited compare | — |
| BYAH Park Ha Biological Technology Co., Ltd. compare | — |
| Household & Personal Products industry median | 23.5× |
| Consumer Defensive sector median | 18.1× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)